Form D · Biotechnology
Synergy Biomedical, LLC
Collegeville, PA · CIK 0001531058
Offering snapshot reported Mar 5, 2014 · SEC filing
- Reported sold
- $612K Offering amount: $1.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 18, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 5, 2014 | Initial | $611,900 | No comparison | 5 | SEC filing |
| Jul 23, 2012 | Initial | $412,212 | No comparison | 5 | SEC filing |
| Sep 29, 2011 | Initial | $200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212960
Source: Form D, filed Mar 5, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Anderson | Director |
| Mark Borden | Director, Executive |
| Glenn Kenney | Director |
| Richard Kienzle | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Springhouse Drive, Suite 108
Collegeville, PA, 19426
Collegeville, PA, 19426